BRIEF published on 04/18/2025 at 12:30, 1 year 4 months ago 4finance S.A. Announces Sale of TBI Bank to Advent Acquisition Private Equity 4finance TBI Bank Advent
BRIEF published on 04/18/2025 at 12:30, 1 year 4 months ago 4finance SA annonce la vente de TBI Bank à Advent Acquisition Capital-investissement 4finance Banque TBI Avènement
BRIEF published on 04/18/2025 at 12:09, 1 year 4 months ago Turkiye Garanti Bankasi A.S. Increases Investment in Subsidiary Capital Increase Financial Disclosure Turkiye Garanti Bankasi Garanti Finansal Kiralama TRY 6 Billion
BRIEF published on 04/18/2025 at 12:09, 1 year 4 months ago Turkiye Garanti Bankasi AS augmente son investissement dans sa filiale Augmentation De Capital Divulgation Financière Banque De Garantie De Turquie Garantie Financière Kiralama 6 Milliards De Livres Sterling
BRIEF published on 04/18/2025 at 12:04, 1 year 4 months ago Turkiye Garanti Bankasi A.S. Announces Audit Committee Changes Board Of Directors Governance Appointment Garanti BBVA Audit Committee
BRIEF published on 04/18/2025 at 12:04, 1 year 4 months ago Turkiye Garanti Bankasi AS annonce des changements au comité d'audit Gouvernance Conseil D'administration Rendez-vous Comité D'audit Garantie BBVA
BRIEF published on 04/18/2025 at 11:46, 1 year 4 months ago Tikehau Capital Discloses Share Repurchases from April 11-17, 2025 Market Regulation Tikehau Capital Shares Repurchase Average Share Price XPAR Transactions
BRIEF published on 04/18/2025 at 11:46, 1 year 4 months ago Tikehau Capital annonce ses rachats d'actions du 11 au 17 avril 2025 Rachat D'actions Régulation Du Marché Tikehau Capital Cours Moyen De L'action Transactions XPAR
BRIEF published on 04/18/2025 at 10:05, 1 year 4 months ago Valneva Updates on Chikungunya Vaccine Recommendation in the U.S. Valneva Chikungunya Vaccine IXCHIQ® ACIP Recommendation U.S. Travelers
BRIEF published on 04/18/2025 at 10:05, 1 year 4 months ago Valneva met à jour sa recommandation concernant le vaccin contre le chikungunya aux États-Unis Valneva Voyageurs Américains Vaccin Contre Le Chikungunya IXCHIQ® Recommandation De L'ACIP
Published on 09/11/2026 at 04:00, 8 hours 43 minutes ago Torq Announces Debt Settlement and Corporate Update
Published on 09/10/2026 at 22:25, 14 hours 18 minutes ago Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 15:20, 21 hours 23 minutes ago MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 21 hours 43 minutes ago All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Published on 09/11/2026 at 11:43, 1 hour ago Skyborn reaches Financial Close on the Gennaker offshore wind farm project
Published on 09/11/2026 at 11:35, 1 hour 7 minutes ago EQS-Adhoc: Correction of a release from 10/09/2026, 19:35 CET/CEST - United Internet AG: Group subsidiaries 1&1 AG and IONOS Group SE launch transformation programs
Published on 09/11/2026 at 11:30, 1 hour 13 minutes ago Galimedix Therapeutics to present functional feasibility data from Phase 2 eDREAM study in geographic atrophy at 26th EURETINA Congress
Published on 09/11/2026 at 10:15, 2 hours 28 minutes ago TCMA Receives Two National Awards, Highlighting Thailand’s Cement Industry Progress Towards Net Zero 2050
Published on 09/11/2026 at 07:00, 5 hours 43 minutes ago Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 5 hours 43 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 5 hours 43 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 17 hours 13 minutes ago Availability of the 2026 Interim Financial Report
